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a b s t r a c t
Background: Bone marrow biopsy and aspiration (BMBA) is a diagnostic procedure within
the field of internal medicine. The intensity of the pain felt by the patients often goes
unrecognized by the medical staff. No extant studies have addressed pain intensity expe-
rienced during each particular step of a BMBA. Objectives: The aim was to analyze the
pain intensity and explore the extent to which the technique applied by the doctor
performing the biopsy influences the pain level. Methods: A survey comprising 17 ques-
tions was created and it addressed characteristics of the patients, previous experience
and pain intensity on each step of the procedure. Results: 125 patients were enrolled into
the study. Age (p = 0.009), gender ( p = 0.02), pain during previous biopsies (p < 0.0001) and
adequate information (p = 0.04) were shown to have significant impact on the pain inten-
sity levels. There was a significant difference in the pain levels on different steps of the
procedure perceived by the patients, when comparing the doctors with similar expe-
rience performing BMBA (p = 0.01 to p < 0.0001 depending on the step of the procedure).
Conclusions: The differences in the pain scores between the doctors are most likely
caused by differences in technique of BMBA. The analysis of the individual technique of
the doctors performing the least painful biopsies may give answers needed for educatio-
nal intervention aimed at pain reduction during BMBA.
© 2016 Polskie Towarzystwo Hematologów i Transfuzjologów, Instytut Hematologii i
Transfuzjologii. Published by Elsevier Sp. z o.o. All rights reserved.
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Bone marrow biopsy and aspiration (BMBA) is an essential
diagnostic procedure within the field of internal medicine,
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z o.o. All rights reserved.histopathological and cytopathological examination and
immunophenotyping [1–3]. A BMBA can also be a painful
procedure and a significant ordeal for many patients. The
significance and importance of the patient's experience
with BMBA remains unrecognized by many physicians [4].
There are no clear guidelines on how to reduce this pain,kologii i Chorób Wewnętrznych, SPCSK, ul. Banacha 1a, 02-097
w, Instytut Hematologii i Transfuzjologii. Published by Elsevier Sp.
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physicians underestimate the severity of the pain [5–7].
Research thus far has focused on the pharmacological
reduction of pain using local anesthesia, usually Lidocaine or
a similar agent [8]. Various trials have addressed other means
of analgesia for the pain associated with this procedure,
including pharmacological trials administering combinations
of analgesics, sublingual fentanyl, intravenous sedation with
benzodiazepines or, most recently, nitrous oxide/oxygen or
nitrous oxide alone [9]. Alternative methods of reducing pain
have also been investigated, including hypnosis as an adjunct
to local anesthesia, cognitive behavioral therapy (shown to be
ineffective), art/music therapy and contralateral ice massage
during the procedure [9–12]. Recently, powered bone marrow-
acquiring devices were tested and compared with the classi-
cal manual approach [9].
However, these studies have not addressed in detail one
of the most important factors contributing to pain during
the procedure, physician technique. To date, the findings
have been contradictory as to whether the experience of the
physician influences the pain experienced by the patients
during biopsies. The results of some studies demonstrate
lower perceived pain when experienced doctors perform
BMBA, and other studies fail to show a difference [9]. No
international guidelines have been proposed for techniques
to minimize pain during BMBA, and this knowledge has
typically been passed from older to younger doctors. More-
over, the pain analyses in extant studies are relatively
inaccurate; patients are typically asked for their general pain
sensation during the procedure. The BMBA includes several
stages: anesthesia, entering the bone with the needle, bone
marrow aspiration and bone extraction; each stage can
be characterized by a distinct intensity of pain [4]. Because
each of the steps depends on the technique applied by
the operator performing the biopsy, the question arises: Will
experienced operators differ from each other in the way that
they perform a biopsy? The aim of this study was to analyze
for the first time the pain felt by patients during various
stages of the BMBA. Moreover, we wanted to identify which
factors influence pain during the various stages and, most
notably, the extent to which the technique applied by the
doctor performing the biopsy influences the pain level.
Material and methods
The study was conducted at the Department of Hematology,
Oncology and Internal Medicine at the Medical University of
Warsaw. All patients over 18 years of age who were
scheduled for a BMBA were offered enrollment into this
study between 2011 and 2013. Only the patients who signed
informed consent were asked to fill the questionnaires.
Otherwise there were no other inclusion or exclusion
criteria. The study design was approved by the Bioethics
Committee of the Medical University of Warsaw. The
doctors performing the biopsies in this study were typically
hematologists or hematologists-in-training, and they all had
a high level of experience performing BMBAs (per doctor the
number performed ranged from a few hundred to a few
thousand).The various parts of the procedure and the pain intensity
experienced by the patients were assessed by creating a
17-question survey. The questions included patient general
characteristics (age, weight, height and occupation), the
history of previous BMBA (number and pain intensity of
previous procedures) and whether any premedication was
taken. One crucial question included 7 sub-questions that
addressed the pain intensity during each step of the BMBA.
We asked for the level of pain intensity before the procedure
and during local anesthesia administration, biopsy needle
insertion through soft tissues, biopsy needle insertion
through the bone, bone marrow aspiration and, if applicable,
bone extraction. We asked the patient to report the pain
intensity experienced after the procedure. Other questions
solicited information regarding whether the pain experi-
enced during each step was significant (intolerable) and
what point on the Visual Analogue Scale (VAS) signified
pain intensity that was considered intolerable. General
satisfaction, environmental factors, the doctor's approach
and whether enough information was provided about the
procedure were also assessed. Finally, patients were given
the opportunity to express their own thoughts on factors
influencing pain and possible ways of reducing it.
As the questionnaire addresses the pain on different
stages of procedure which can be forgotten or not under-
stood by patients we run a pretrial quality check of
questionnaire. Questionnaires were consulted with patients
and their opinion was asked on possible problems with
assessment of the pain on different stages of biopsy. The
patients did not report any difficulties in filling the ques-
tionnaire which was later approved for the study.
All assessments of pain intensity were made using the
Visual Analogue Scale (VAS), a 100 mm horizontal baseline
anchored with 2 descriptions, “no pain” on the left-hand
side and “worst imaginable pain in my life” on the right-
hand side [13, 14]. The questionnaire was administered to
the patient immediately after the procedure, and the
patients were asked to return it as soon as possible before
leaving the clinic. The surveys were reviewed, edited and
approved by all authors. All data obtained were analyzed
using Akademistatistik, Sahlgrenska Academy, Gothenburg
University, Sweden.
The BMBA procedure was conducted with the patient in
a supine position for sternal biopsies or prone for biopsies of
the iliac crest. Aseptic technique was employed, and the area
was scrubbed and draped with the sampling site exposed.
The choice of biopsy site, the sternum or spina iliaca, was
made by the physician performing the procedure according to
the clinical indications for each patient. If only a marrow
aspiration was required, the sternal site was preferred.
A local anesthetic, 2% Lidocaine, was injected subcuta-
neously at the sample site: up to 2 ml for the sternum and
up to 10 ml for the spina iliaca, depending on the effect of
the anesthetic. A few minutes after injecting the Lidocaine,
the doctor gently tapped the bone with the tip of the needle
while asking the patient to report any painful sensations to
assess the efficacy of the local anesthesia. The sternal
biopsies were made with 15 G  5–30 mm bone marrow
aspiration needles, and the trephine biopsies were made
with 11 G  100 mm Jamshidi-type needles.
Table I – Demographic data
Variable Characteristics Number of
patients (%)
Mean VAS
Gender Male 66 (53%) 1.26
Female 59 (47%) 1.87
Age <20 0 0
20–29 6 (5%) 1.84
30–39 7 (6%) 1.60
40–49 12 (9%) 1.61
50–59 26 (21%) 1.12
60–69 47 (38%) 1.54
70–79 20 (16%) 1.93
>80 4 (3%) 2.16
N/A 3 (2%) 1.21
BMI <18.5 2 (1.5%) 2.07
18.5–24.9 45 (36%) 1.55
25–29.9 51 (41%) 1.58
>30 22 (17.5%) 1.50
N/A 5 (4%) 1.51
Occupation Manual work 39 (31%) 1.59
Intellectual work 53 (42%) 1.41
N/A 33 (27%) 1.76
Disease Leukemia 27 (21%) 1.56
Lymphoma 15 (12%) 1.99
Multiple myeloma 16 (13%) 1.44
Myeloprolif. disorders 15 (12%) 1.71
Others 52 (42%) 1.42
Procedure Sternum aspiration 29 (23%) 1.83
Spina iliaca aspiration 36 (29%) 1.29
Spina iliaca aspiration 60 (48%) 1.58
+ Biopsy
Prior 0 42 (34%) 1.38
Procedure 1 17 (14%) 1.87
2 23 (18%) 1.74
3 8 (6%) 1.64
4 6 (5%) 1.79
>5 29 (23%) 1.33
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used to insert the biopsy needle into the soft tissue until it
reached the bone. Manual pressure was applied by rotating
the stylet clockwise and anti-clockwise until the bone
marrow cavity was reached, confirmed by a reduction in
resistance.
The stylet was removed to enable aspiration of the bone
marrow. If a bone biopsy was required, a new sampling site
was created by repositioning the same needle to prevent the
formation of an artifact in the bone at the aspiration site.
The acquired specimen was placed in a formalin solution
and sent for histopathological examination. The aspiration
needle was discarded.
Once the BMBA was completed, the biopsy needle was
removed; pressure was applied with gauze to prevent bleed-
ing; an adhesive patch was affixed; and a bag of ice was
placed over the procedure site. Physicians who chose the
sternum as the sampling site followed the same technique as
described with the exception that only aspirations and no
bone biopsies were performed. After the procedure was
completed, patients were routinely asked to remain in the
clinic for 1 h (to check for possible bleeding at the insertion
site), during which time the survey data were collected.
Results
Out of 125 patients interviewed, 66 (53%) were males and 59
(47%) were females. The basic demographic data are shown
in Table I. None of the patients in the study received
premedication. None of the patients reported problems in
understanding of filling the questionnaire. Nearly all of the
patients (124 patients, 99.2%) experienced painful sensa-
tions, whereas only one (0.8%) patient reported no pain. The
patients were asked first what was the significant level of
pain for them – to self-assess the borderline intensity of
significant pain. The patients regarded the VAS pain score
of 3.67 as significant. This score level was used later to
compare with actual pain felt during the biopsy and 12
patients (9.6%) presented a mean pain score of 3.67 after
the procedure. Using the VAS, 48 patients (38.4%) reported
a score of 3.67 during one or more of the BMBA procedure
steps. Regardless of the VAS pain score, 21 patients reported
experiencing intolerable pain during the procedure, and
13 out of those underwent aspirations and bone biopsies
from the spina iliaca. All 13 patients (100%) stated that
their experience of pain during the bone extraction was
significant.
Females were more sensitive to pain than were males
(p = 0.0201). Age had a positive impact on the average pain
sensitivity, with older the patients reporting a higher pain
sensitivity comparing to their younger peers (p = 0.0086).
BMI did not have a significant effect on pain (p = 0.3327).
The occupation of the patient, specifically whether it
was manual or intellectual, did not have a significant effect
on the pain intensity (p = 0.7109). The 15 patients diagnosed
with lymphoma reported the highest VAS pain scores
(VAS 1.99).
There was not a significant difference between patients
who had not undergone any previous biopsies and patientswho had undergone one previously, despite a trend suggest-
ing that the more procedures a patient has experienced, the
less their pain intensity. A previous pain score of 3.67
(p < 0.001) and adequate information given by medical
personnel (p = 0.020703) had significant impacts on the
intensity of patient pain. Adequate communication with
the doctor particularly prior BMBA (p = 0.0333), during bone
extraction (p = 0.0253) and post BMBA (p = 0.0267), also had
significant impacts on the intensity of patient pain. Sum-
mary of factors influencing the pain felt by the patient
during the biopsy is shown in Table II.
Comparing aspirations from the sternum and spina iliaca
indicated that aspirations from the sternum were more
painful than were aspirations from the iliac crest at each
procedural step. Patients undergoing aspiration from the
sternum reported VAS scores of 2.32 vs. 2.16 for aspirations
from the spina iliaca (p = 0.7809). When comparing aspira-
tions at these 2 sites, the stage involving the application of
local anesthesia together with the biopsy needle insertion
showed a significant difference in pain (Table III).
Twelve doctors participated in the study. Two doctors
enrolled more than 20 patients, whereas the other doctors
enrolled only a few patients each. For the statistical analy-
sis, the 2 doctors who had enrolled the most patients were
analyzed and compared to the combined results from other
Table II – Main factors connected with lower pain during
the bone marrow aspiration and biopsy
Variable p Corrected
p-value
Younger age of patient 0.0086 0.0172
Male gender of patient 0.0201 0.0201
Skills of the doctor performing the biopsy 0.0004 0.0012
Pain scores <3.67 during previous BMBA <0.0001 <0.001
Adequate information prior to procedure 0.0365 <0.001
This table summarizes significant pain influencing factors. p-
Values have been corrected for mass significance using Bonferro-
ni–Holms method.
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difference between the doctors. Doctor B was less likely to
cause pain during each step of the procedure when com-
pared to doctor A (p < 0.001) and to the combined results
from the other doctors (p < 0.001) (Table IV). To exclude
a possible patient selection bias, the self-reported pain
sensitivity levels of patients treated by doctor A and doctor
B were compared and showed no significant difference in
self-reported pain sensitivity, mean VAS score of 2.97 vs.
4.83 (p = 0.07599). Therefore, the doctor performing the
biopsy has a significant impact on the average pain felt
during the procedure (p = 0.0004).Table III – Role of procedural site as pain influencing factor
Variable Sternum 
Pre-procedural pain 0.69 
Local anesthesia application 2.38 
Biopsy needle insertion into soft tissue 2.38 
Bone penetration 2.18 
Bone marrow aspiration 2.32 
Bone extraction – 
Post procedural pain 1.07 
This table comparing pain intensity levels obtained during bone marrow 
pain intensity levels during BMBA.
Table IV – Differences in pain scores between doctors perform
Variable Prior BMBA L. anesthesia1 B. needle sft.2
Dr. A vs. Dr. B
VAS scores 0.73/0.21 2.04/1.11 1.97/0.79 
p values 0.2541 0.0053 0.0188 
Dr. A vs. Dr. C-L
VAS scores 0.73/0.27 2.04/1.18 1.97/1.72 
p values 0.3480 0.2190 0.8388 
Dr. B vs. Dr. C-L
VAS scores 0.21/0.27 1.11/1.18 0.79/1.72 
p values 0.5899 0.0133 0.0007 
This table shows mean VAS scores during each particular step of BMBA a
similar background regarding experience and number of biopsies perform
1 Local anesthesia application.
2 Biopsy needle penetration through soft tissue.
3 Biopsy needle penetration through bone.
4 Bone marrow aspiration.
5 Bone extraction.According to the patients, the 3 most frequently men-
tioned factors influencing pain were proper anesthesia
(mentioned 44 times), bone marrow biopsy technique (men-
tioned 18 times) and the attitude or stress level of the
patient (mentioned 15 times).
Discussion
A bone marrow biopsy and aspiration remains a procedure
that is dreaded by patients worldwide. For many patients,
the pain experienced during this procedure is significant.
Because the procedure is being performed more often and
is expanding in use from hematologists to doctors of
regenerative medicine who require bone marrow as
a source of stem cells, it is likely that the need for marrow
biopsies will increase. To date, research in this field is
limited, and the procedure itself has not changed much
over the years. We hypothesized in our previous work [9]
that the technique applied by the physician (rather than
his/her experience in performing the biopsy) might play
a significant role in reducing pain. To test this hypothesis,
we developed a new approach in which we asked patients
to report their pain intensity levels at each step of the
procedure, analyzing for the first time the pain intensity at








aspirations from sternum vs. aspirations from spina iliaca and mean
ing BMBA
B. needle pntr.3 Bone asp.4 Bone extr.5 Post BMBA
2.36/0.80 2.38/0.76 1.61/1.14 0.23/0.26
0.0067 0.0121 0.2912 0.3278
2.36/2.22 2.38/2.86 1.61/3.06 0.23/0.87
0.8920 0.5261 0.3333 0.1502
0.80/2.22 0.76/2.86 1.14/3.06 0.26/0.87
0.0001 <0.0001 0.0058 0.0092
nd the p values when comparing doctors. Doctor A and doctor B have
ed.
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Moreover, the physician can use the survey questions to
address the pain that patients experience at the various
stages of the biopsy and then use the data as constructive
feedback for improving his or her operating technique. This
tool may reduce pain for patients undergoing BMBA. The
study also shows that 2 very experienced doctors (each of
whom had performed more than 3000 biopsies) differ
significantly in their techniques used to perform biopsies.
This finding indicates that the technique and behavior of
the operator during the biopsy is a decisive factor in the
biopsy experience of the patient. The patients of doctor A,
whose pain scores were significantly lower, also reported
better communication with the doctor and having received
more adequate information. Surprisingly, the aspiration is
not the most painful part of the procedure – this can be
easily explained once the technique of aspiration is
watched. The speed of the suction and the volume of the
obtained marrow influence the pain of the patient. As our
center has very strict policy on minimal volumes of marrow
samples they remain low (usually 2–10 ml) compared to
other centers where quite often much higher volumes of
marrow are sampled for scientific use or biobanking. This
could explain that the aspiration was usually not the most
painful part of the procedure in contrast to experience in
other centers.
Another question is how the technique of the operator
with classical BMBA needle will compare to the powered
BMBA devices. One recent systematic review and meta-
analysis of 5 randomized clinical trials indicated an advan-
tage of powered devices over manual techniques. One of
the conclusions of this review was that powered systems
could offer an alternative for patients with high anxiety
and sensitivity to pain [15]. However, when we indirectly
compare the VAS scores belonging to the patients treated
by the most skilled doctor in performing BMBA with
minimal pain, he surpasses with a clear margin the results
of the trials with powered devices. In our opinion this fact
questions the data presented in studies exploring the
effectiveness and impact of powered BMBA devices on pain
scores, as they can clearly be biased by comparing the pain
scores of powered devices with physicians who did not yet
achieve excellence in minimizing the BMBA associated
pain. Therefore, a comparison of the top performing physi-
cians using classical BMBA needles with physicians using
powered BMBA devices would be more conclusive in explor-
ing and answering the question to what extent the techni-
que chosen and applied by the physician influences the
pain level.
The study has some obvious limitations. This is a single
center study and there was no randomization. The patients
mostly knew the doctors and this could have an influence
on pain assessment – there could be possible effect on
giving better “grades” to the doctors that the patients like.
The only possibility to dissect this effect would be to
randomly assign the patients to different doctors who they
do not know – which is rather hard to accomplish given the
multiple chances that the patient has to get acquainted with
different doctors at the center. Given these limitations, the
pool of 125 biopsies is one of the biggest published so farand it is the first study that tried to dissect the pain felt on
different stages of biopsy – to show where improvements
could be made, and also provide the doctors instant feed-
back on when their patients feel the pain. The study shows
differences in BMBA skills between the doctors at one
center. We were only limited to 2 doctors performing
enough biopsies to allow for valid analysis and we had to
use pooled results of the rest of the doctors to show how
those results compare to the practice at the center. This is
not objective test, still it points to differences in skills that
can be assessed and later used for education and training
purposes.
A general misconception by physicians is that there is no
difference in pain intensity experienced during bone mar-
row aspirations of the sternum versus bone marrow aspira-
tions of the spina iliaca. Our study results demonstrate that
an aspiration of the sternum is more painful at each step of
the procedure. Moreover, the sternum and spina iliaca show
significant differences in the pain scores during the applica-
tion of local anesthesia and bone marrow needle insertion
through soft tissue. Increased anxiety served as an under-
lying factor that increased the sensation of pain [16–18]
during sternal aspirations. The sight of the needle that
delivers the syringe filled with local anesthetic can be
a stressful moment for many patients, as can the sight of
the biopsy needle, which is inserted after applying the local
anesthetic.
We also asked patients to report their perspectives on
important pain influencing factors. They mentioned
proper anesthesia, the technique of the operator and their
own stress levels prior to the BMBA. These data and the
findings from this study are congruent with those of other
studies in the field [9]. Therefore, 3 ways the operator
can influence the patient's experience include taking care
to anesthetize the biopsy site fully, using biopsy techni-
ques that reduce pain and reducing stress by adequately
communicating with the patient. Our study also shows
clear directions for further research on this topic. We are
open to sharing our questionnaire with any center
involved in research of the standardization of BMBA
technique.
In conclusion, this is the first study to address the pain
experienced by the patient at each step of a BMBA. The
experience of pain can be reduced by simple measures, such
as properly communicating and providing appropriate and
adequate information. Further research should be under-
taken to establish clear and standardized evidence-based
guidelines on how to perform a BMBA with minimal pain.
Medical personnel underestimate the significance and sever-
ity of the pain felt by patients, and a greater awareness
should be raised via staff education. Especially cooperation
with specialist outside hematology, such as anesthesiology
and intensive care might improve the pain prevention
during the BMBA. Neglecting proper communication can
lead to unjustified fear and increased stress levels in
patients, which in turn can affect the patient's attitude
toward further treatment. Currently, no mechanical device
has surpassed the best skills of our doctors; it is the
individual physician's technique that plays a crucial role
and that needs to be improved.
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Informed consent was obtained from all patients for being
included in the study.
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